OTC Markets OTCQB - Delayed Quote USD
CS Diagnostics Corp. (CSDX)
0.0684
+0.0084
+(14.00%)
As of 1:19:48 PM EDT. Market Open.
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Thomas Fahrhöfer | Chairman & CEO | -- | -- | 1970 |
| Mr. Thomas J. Migotsch | Chief Financial Officer | -- | -- | 1977 |
| Mr. Thomas Graus | Secretary & Director | -- | -- | 1983 |
CS Diagnostics Corp.
- Sector:
- Healthcare
- Industry: Medical Devices
Description
CS Diagnostics Corp. manufactures and sells medical products for medicine, radiology, cardiology, and radiation therapy in Germany and internationally. The company offers injectors, pistons, hose systems, PCR tests, medicines, and gloves. It also operates as a pharmaceutical wholesaler. The company was formerly known as FlashZero Corp. and changed its name to CS Diagnostics Corp. in August 2023. The company was incorporated in 1996 and is based in Neuss, Germany.
Corporate Governance
CS Diagnostics Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available